Raia Drogasil S.A.
RADL3
Rank in Stocks
#2628
Raia Drogasil S.A. engages in the retail sale of medicines, perfumery, personal... Raia Drogasil S.A. engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics and dermocosmetics and specialty medicines in Brazil. The company sells its products through stores, telesales, and call centers. Raia Drogasil S.A. was founded in 1905 and is headquartered in São Paulo, Brazil.
Share Price
$4.15
Market Cap
$7.25B
Change (1 day)
1.03%
Change (1 year)
14.45%
Country
BR
Trade Raia Drogasil S.A. (RADL3)
Category
Consumer Defensive
Revenue for Raia Drogasil S.A. (RADL3)
Revenue in Jun 2026 TTM: $8.63B
According to Raia Drogasil S.A. latest financial reports the company's current revenue (TTM) is $8.63B. In 2023 the company made a revenue of $7.00B an increase over the revenue in the year 2022 that was $5.50B. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Raia Drogasil S.A. from 2003 to 2026
Revenue at the end of each year
| Year | Revenue | Change |
|---|---|---|
| 2026 (TTM) | $8.63B | 37.23% |
| 2024 | $6.29B | -10.17% |
| 2023 | $7.00B | 27.34% |
| 2022 | $5.50B | 26.96% |
| 2021 | $4.33B | 12.08% |
| 2020 | $3.86B | -11.58% |
| 2019 | $4.37B | 14.59% |
| 2018 | $3.81B | -4.41% |
| 2017 | $3.99B | 15.31% |
| 2016 | $3.46B | 53.70% |
| 2015 | $2.25B | -18.46% |
| 2014 | $2.76B | 4.57% |
| 2013 | $2.64B | 0.52% |
| 2012 | $2.63B | 79.53% |
| 2011 | $1.46B | 21.13% |
| 2010 | $1.21B | 22.32% |
| 2009 | $987.43M | 81.96% |
| 2008 | $542.66M | 15.32% |
| 2007 | $470.55M | 49.32% |
| 2006 | $315.13M | 37.28% |
| 2005 | $229.55M | 43.55% |
| 2004 | $159.91M | 34.55% |
| 2003 | $118.85M | 0.00% |
Revenue for similar companies or competitors
| Company | Revenue | Revenue Difference | Country |
|---|---|---|---|
| $87.03B | 908.34% |
US
|
|
| $51.67B | 498.60% |
FR
|
|
| $21.05B | 143.84% |
US
|
|
| $7.28B | -15.60% |
IN
|
|
| $15.05B | 74.36% |
US
|
